PDGFRB and neoplasm: Moreover, our analysis of tumor microenvironment both in our orthotopic tumors and in PTC clinical samples provides evidence that metastatic BRAFV600E-PTC with MCL1 and P16 copy number alterations are enriched with PDGFRB-positive stromal cells (i.e. pericyte).